NYSE · Medical Instruments & Supplies · USD
Alcon Inc. (ALC) Stock Analysis
Alcon Inc. (ALC) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ALC Key Statistics
As of Oct 21, 2026Trading
- Open
- $67.56
- Previous Close
- $67.83
- Day's Range
- 67.09–68.09
- 52-Week Range
- 61.84–87.64
- Volume
- 1.10M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.73
Valuation
- Market Cap
- $32.60B
- P/E Ratio
- 51.08
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 17.01
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.22
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 3.00
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.32
Financials (FY)
- Revenue (FY)
- $10.40B+4.94%
- Net Income (FY)
- $980.00M−3.73%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 5.92%
- Shares Outstanding
- 483.40M
- 1-Year Return
- −10.56%
Dividend and dates
- Dividend
- $0.36+0.53%
- Ex-Dividend Date
- May 6, 2026
- Earnings Date
- November 10, 2026
- Avg Volume
- 1.77M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, ALC closed at $67.43, −10.56% over 1 year.
Alcon Inc. (ALC) has a market capitalization of $32.60B.
In fiscal 2025, ALC reported revenue of $10.40B.
ALC Stock Return by Calendar Year
Alcon Inc. (ALC) return since Apr 2019: what $10,000 became
- 1 year
- $10,000 $8,944
- −10.56%
- 5 years
- $10,000 $8,417
- −15.83%
- Since Apr 2019
- $10,000 $11,843
- +18.43%
If you had invested $10,000 in Alcon Inc. (ALC) at the close on April 9, 2019, the earliest close on record here, it would have been worth $11,843 at the close on October 21, 2026: +18.43% in total, +2.27% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −14.02% |
| 2025 | −6.84% |
| 2024 | +9.02% |
| 2023 | +14.32% |
| 2022 | −21.09% |
| 2021 | +32.23% |
| 2020 | +16.63% |
| 2019 (partial year) | −2.53% |
As of October 21, 2026.
ALC Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $10.40B | $980.00M | 9.4% |
| 2024 | $9.91B | $1.02B | 10.3% |
| 2023 | $9.46B | $974.00M | 10.3% |
| 2022 | $8.72B | $335.00M | 3.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $10.40B | $5.75B | $1.36B | $980.00M | 9.4% |
| 2024 | $9.91B | $5.51B | $1.41B | $1.02B | 10.3% |
| 2023 | $9.46B | $5.25B | $1.04B | $974.00M | 10.3% |
| 2022 | $8.72B | $4.75B | $672.00M | $335.00M | 3.8% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
ALC Dividend History
Dividends per share, 2025 · 1 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $0.36 | 1 | — |
| 2025 | $0.33 | 1 | +25.4% |
| 2024 | $0.26 | 1 | +11.9% |
| 2023 | $0.24 | 1 | +15.1% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $0.36 | 1 | — |
| 2025 | $0.33 | 1 | +25.4% |
| 2024 | $0.26 | 1 | +11.9% |
| 2023 | $0.24 | 1 | +15.1% |
| 2022 | $0.21 | 1 | +86.4% |
| 2021 | $0.11 | 1 | — |
Most recent payment: $0.36 per share, ex-dividend May 5, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
ALC Valuation vs Medical Instruments & Supplies Median
Median of 50 stocks| Metric | ALC | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/E | 51.08 | 31.19 | 64% above |
| P/S ratio | 3.00 | 2.60 | 16% above |
| Profit margin | 5.92% | 1.62% | 4.3 pts above |
Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
YahooFDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
YahooAlcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio.
BenzingaBTIG Maintains Buy on Alcon, Lowers Price Target to $74
BenzingaBarclays Initiates Coverage On Alcon with Equal-Weight Rating, Announces Price Target of $70
BenzingaIntroducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
Yahoo
All 20 articles ↓Show fewer ↑
Alcon (SWX:ALC) Stock Trades Above Fair Value On Earnings Pressure
YahooNeedham Reiterates Buy on Alcon, Maintains $98 Price Target
BenzingaIs it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
YahooAlcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
YahooAre Options Traders Betting on a Big Move in Alcon Stock?
YahooAlcon: A Re-Rating In Eyesight
SeekingAlphaAlcon (SWX:ALC), What Is Behind The Fresh Attention?
YahooSGA Exits Alcon (ALC) as Cataract Demand Slows and Competition Rises
YahooWhat Makes Alcon (ALC) a Bullish Bet?
YahooAlcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
SeekingAlphaAlcon: Historical Growth Significantly Understates Potential
SeekingAlphaJP Morgan Maintains Neutral on Alcon, Raises Price Target to $78.4
BenzingaMizuho Maintains Outperform on Alcon, Raises Price Target to $85
BenzingaAlcon Inc. (ALC) Q2 2026 Earnings Call Transcript
SeekingAlpha
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$151.25B
BDXBecton, Dickinson and Company
$52.79B
MDLNMedline Inc.
$47.51B
RMDResMed Inc.
$34.63B
WSTWest Pharmaceutical Services, Inc.
$27.69B
SOLVSolventum Corporation
$14.75B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B














